AKT1 and glioma: Compared with the control, TGF-β treatment in GSC 1123 and R39 cells induced AEBP1 expression, activated p-AKT (Figure 5A), and promoted cell proliferation (Figure 5B) and glioma sphere formation (Figure 5C).